Research Institute of Molecular Pathology (IMP)
Forschungsinstitut für Molekulare Pathologie GmbH (IMP)

Founded

1985

Staff

285

Organization type

research and education institutions

Region

Vienna

Cluster

LISAvienna

Focus R&D

basic research

Research area

biological sciences

The Research Institute of Molecular Pathology (IMP) is a leading basic research institute in Vienna, Austria. Its 16 research groups with scientists from 40 countries address fundamental questions in molecular biology. Funded primarily by Boehringer Ingelheim and with unconstrained academic freedom, the IMP offers an ideal environment for curiosity-driven biomedical research. As part of Vienna BioCenter, the IMP is embedded in one of Europe’s biggest life science hubs with over 2,000 employees.

R&D:The common goal of IMP scientists is to elucidate the mechanisms and principles that underlie complex biological processes. The 16 independent research groups currently focus on the following areas: - Molecular and Cellular Biology - Structural Biology and Biochemistry - Gene Expression and Chromosome Biology - Stem Cell Biology and Development - Immunology and Cancer - Neurobiology